Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases

Background Acquiring sputum cultures from infants is considered challenging. We describe their yield in infants with cystic fibrosis (CF) and other chronic suppurative lung diseases (CSLDs). Methods Retrospective medical record review over a 4‐year period, for infants aged 0–2 years with ≥2 airway b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric pulmonology 2020-12, Vol.55 (12), p.3421-3428
Hauptverfasser: Stafler, Patrick, Zaks‐Hoffer, Gal, Scheuerman, Oded, Ben‐Zvi, Haim, Mussaffi, Huda, Mei‐Zahav, Meir, Steuer, Guy, Levine, Hagit, Bar‐On, Ophir, Mantin, Hadas, Prais, Dario, Blau, Hannah
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3428
container_issue 12
container_start_page 3421
container_title Pediatric pulmonology
container_volume 55
creator Stafler, Patrick
Zaks‐Hoffer, Gal
Scheuerman, Oded
Ben‐Zvi, Haim
Mussaffi, Huda
Mei‐Zahav, Meir
Steuer, Guy
Levine, Hagit
Bar‐On, Ophir
Mantin, Hadas
Prais, Dario
Blau, Hannah
description Background Acquiring sputum cultures from infants is considered challenging. We describe their yield in infants with cystic fibrosis (CF) and other chronic suppurative lung diseases (CSLDs). Methods Retrospective medical record review over a 4‐year period, for infants aged 0–2 years with ≥2 airway bacterial cultures acquired by deep suction or induced sputum ≥4 weeks apart. Data included demographics, culture results, and clinical status. Results A total of 98 infants (16 CF) were evaluated and 534 sputum cultures acquired, 201 in CF and 333 in CSLD. There were 12 (2–23), median (range) cultures/CF infant, and 3 (2–21)/CSLD infant. Age at first culture was 3.8 (1–19.5) months for CF and 10.4 (0.5–22) months for CSLD; p = .016. In total, 360 cultures (67%) were positive for any bacteria, with 170/234 (73%) positive during exacerbations, compared with 190/300 (63%) during routine visits; p = .05. More infants with CF than CSLD had cultures positive for Staphylococcus aureus (SA; 75% vs. 34%; p = .004) throughout the period. Pseudomonas aeruginosa (PA) was common in both CF and CSLD (56% and 44%, respectively; p = .42) and increased over time for CF but was high throughout for CSLD. The number of hospital days before PA acquisition was 6 (10.2) for CF and 28.8 (38.7) for CSLD (p = .003). No CF but 6/82 (7%) CSLD infants had chronic PA (p = .56). Conclusions Sputum cultures showed that infection, in particular PA, is common in CF and CSLD whereas SA is more common in CF. Prospective studies are warranted to elucidate the role of active surveillance in guiding antibiotic therapy.
doi_str_mv 10.1002/ppul.25103
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2448410680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2458504380</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3573-4c763b043a8aa31ccca97d956f12708d809f0ecae3bac34b6e9e580aa39a65c93</originalsourceid><addsrcrecordid>eNp90UFP2zAYBmBrAo3CdtkPmCxxmSYFPsexYx-nsjGkSnCg58h1vhQzN8nsGNR_j0u7HThw8uF79OqVX0K-MLhgAOXlOCZ_UQoG_AOZMdC6gErLIzJTtRCFVJKfkNMYHwHyTbOP5IRzAFlymJE_V86s-yFOztIn4xPSoaNxTFPaUJv8lAJG6npqH5xvA_Y09S0GWtItmhB32KyRPrvpIZMw9DkmplwomMk9IfWpX9PWRTQR4ydy3Bkf8fPhPSPLXz_v57-Lxe31zfzHorBc1LyobC35CipulDGcWWuNrlstZMfKGlSrQHeA1iBfGcurlUSNQkG22khhNT8j3_a5Yxj-JoxTs3HRovemxyHFpqwqVTGQCjI9f0MfhxT63C4roURu8aq-75UNQ4wBu2YMbmPCtmHQ7CZodhM0rxNk_PUQmVYbbP_Tf3-eAduDZ-dx-05Uc3e3XOxDXwBUGpIf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2458504380</pqid></control><display><type>article</type><title>Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Stafler, Patrick ; Zaks‐Hoffer, Gal ; Scheuerman, Oded ; Ben‐Zvi, Haim ; Mussaffi, Huda ; Mei‐Zahav, Meir ; Steuer, Guy ; Levine, Hagit ; Bar‐On, Ophir ; Mantin, Hadas ; Prais, Dario ; Blau, Hannah</creator><creatorcontrib>Stafler, Patrick ; Zaks‐Hoffer, Gal ; Scheuerman, Oded ; Ben‐Zvi, Haim ; Mussaffi, Huda ; Mei‐Zahav, Meir ; Steuer, Guy ; Levine, Hagit ; Bar‐On, Ophir ; Mantin, Hadas ; Prais, Dario ; Blau, Hannah</creatorcontrib><description>Background Acquiring sputum cultures from infants is considered challenging. We describe their yield in infants with cystic fibrosis (CF) and other chronic suppurative lung diseases (CSLDs). Methods Retrospective medical record review over a 4‐year period, for infants aged 0–2 years with ≥2 airway bacterial cultures acquired by deep suction or induced sputum ≥4 weeks apart. Data included demographics, culture results, and clinical status. Results A total of 98 infants (16 CF) were evaluated and 534 sputum cultures acquired, 201 in CF and 333 in CSLD. There were 12 (2–23), median (range) cultures/CF infant, and 3 (2–21)/CSLD infant. Age at first culture was 3.8 (1–19.5) months for CF and 10.4 (0.5–22) months for CSLD; p = .016. In total, 360 cultures (67%) were positive for any bacteria, with 170/234 (73%) positive during exacerbations, compared with 190/300 (63%) during routine visits; p = .05. More infants with CF than CSLD had cultures positive for Staphylococcus aureus (SA; 75% vs. 34%; p = .004) throughout the period. Pseudomonas aeruginosa (PA) was common in both CF and CSLD (56% and 44%, respectively; p = .42) and increased over time for CF but was high throughout for CSLD. The number of hospital days before PA acquisition was 6 (10.2) for CF and 28.8 (38.7) for CSLD (p = .003). No CF but 6/82 (7%) CSLD infants had chronic PA (p = .56). Conclusions Sputum cultures showed that infection, in particular PA, is common in CF and CSLD whereas SA is more common in CF. Prospective studies are warranted to elucidate the role of active surveillance in guiding antibiotic therapy.</description><identifier>ISSN: 8755-6863</identifier><identifier>EISSN: 1099-0496</identifier><identifier>DOI: 10.1002/ppul.25103</identifier><identifier>PMID: 33006230</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>airway infection ; Anti-Bacterial Agents - therapeutic use ; Bacteria ; Child ; Child, Preschool ; chronic suppurative lung disease ; Cystic fibrosis ; Cystic Fibrosis - drug therapy ; deep suction ; Female ; Humans ; induced sputum ; Infant ; Infant, Newborn ; Lung diseases ; Lung Diseases - diagnosis ; Lung Diseases - microbiology ; Male ; Prospective Studies ; Pseudomonas aeruginosa ; Retrospective Studies ; Sputum - microbiology ; Suppuration - drug therapy</subject><ispartof>Pediatric pulmonology, 2020-12, Vol.55 (12), p.3421-3428</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3573-4c763b043a8aa31ccca97d956f12708d809f0ecae3bac34b6e9e580aa39a65c93</citedby><cites>FETCH-LOGICAL-c3573-4c763b043a8aa31ccca97d956f12708d809f0ecae3bac34b6e9e580aa39a65c93</cites><orcidid>0000-0001-8880-8212 ; 0000-0002-6683-0264</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fppul.25103$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fppul.25103$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33006230$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stafler, Patrick</creatorcontrib><creatorcontrib>Zaks‐Hoffer, Gal</creatorcontrib><creatorcontrib>Scheuerman, Oded</creatorcontrib><creatorcontrib>Ben‐Zvi, Haim</creatorcontrib><creatorcontrib>Mussaffi, Huda</creatorcontrib><creatorcontrib>Mei‐Zahav, Meir</creatorcontrib><creatorcontrib>Steuer, Guy</creatorcontrib><creatorcontrib>Levine, Hagit</creatorcontrib><creatorcontrib>Bar‐On, Ophir</creatorcontrib><creatorcontrib>Mantin, Hadas</creatorcontrib><creatorcontrib>Prais, Dario</creatorcontrib><creatorcontrib>Blau, Hannah</creatorcontrib><title>Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases</title><title>Pediatric pulmonology</title><addtitle>Pediatr Pulmonol</addtitle><description>Background Acquiring sputum cultures from infants is considered challenging. We describe their yield in infants with cystic fibrosis (CF) and other chronic suppurative lung diseases (CSLDs). Methods Retrospective medical record review over a 4‐year period, for infants aged 0–2 years with ≥2 airway bacterial cultures acquired by deep suction or induced sputum ≥4 weeks apart. Data included demographics, culture results, and clinical status. Results A total of 98 infants (16 CF) were evaluated and 534 sputum cultures acquired, 201 in CF and 333 in CSLD. There were 12 (2–23), median (range) cultures/CF infant, and 3 (2–21)/CSLD infant. Age at first culture was 3.8 (1–19.5) months for CF and 10.4 (0.5–22) months for CSLD; p = .016. In total, 360 cultures (67%) were positive for any bacteria, with 170/234 (73%) positive during exacerbations, compared with 190/300 (63%) during routine visits; p = .05. More infants with CF than CSLD had cultures positive for Staphylococcus aureus (SA; 75% vs. 34%; p = .004) throughout the period. Pseudomonas aeruginosa (PA) was common in both CF and CSLD (56% and 44%, respectively; p = .42) and increased over time for CF but was high throughout for CSLD. The number of hospital days before PA acquisition was 6 (10.2) for CF and 28.8 (38.7) for CSLD (p = .003). No CF but 6/82 (7%) CSLD infants had chronic PA (p = .56). Conclusions Sputum cultures showed that infection, in particular PA, is common in CF and CSLD whereas SA is more common in CF. Prospective studies are warranted to elucidate the role of active surveillance in guiding antibiotic therapy.</description><subject>airway infection</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacteria</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>chronic suppurative lung disease</subject><subject>Cystic fibrosis</subject><subject>Cystic Fibrosis - drug therapy</subject><subject>deep suction</subject><subject>Female</subject><subject>Humans</subject><subject>induced sputum</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Lung diseases</subject><subject>Lung Diseases - diagnosis</subject><subject>Lung Diseases - microbiology</subject><subject>Male</subject><subject>Prospective Studies</subject><subject>Pseudomonas aeruginosa</subject><subject>Retrospective Studies</subject><subject>Sputum - microbiology</subject><subject>Suppuration - drug therapy</subject><issn>8755-6863</issn><issn>1099-0496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90UFP2zAYBmBrAo3CdtkPmCxxmSYFPsexYx-nsjGkSnCg58h1vhQzN8nsGNR_j0u7HThw8uF79OqVX0K-MLhgAOXlOCZ_UQoG_AOZMdC6gErLIzJTtRCFVJKfkNMYHwHyTbOP5IRzAFlymJE_V86s-yFOztIn4xPSoaNxTFPaUJv8lAJG6npqH5xvA_Y09S0GWtItmhB32KyRPrvpIZMw9DkmplwomMk9IfWpX9PWRTQR4ydy3Bkf8fPhPSPLXz_v57-Lxe31zfzHorBc1LyobC35CipulDGcWWuNrlstZMfKGlSrQHeA1iBfGcurlUSNQkG22khhNT8j3_a5Yxj-JoxTs3HRovemxyHFpqwqVTGQCjI9f0MfhxT63C4roURu8aq-75UNQ4wBu2YMbmPCtmHQ7CZodhM0rxNk_PUQmVYbbP_Tf3-eAduDZ-dx-05Uc3e3XOxDXwBUGpIf</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Stafler, Patrick</creator><creator>Zaks‐Hoffer, Gal</creator><creator>Scheuerman, Oded</creator><creator>Ben‐Zvi, Haim</creator><creator>Mussaffi, Huda</creator><creator>Mei‐Zahav, Meir</creator><creator>Steuer, Guy</creator><creator>Levine, Hagit</creator><creator>Bar‐On, Ophir</creator><creator>Mantin, Hadas</creator><creator>Prais, Dario</creator><creator>Blau, Hannah</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8880-8212</orcidid><orcidid>https://orcid.org/0000-0002-6683-0264</orcidid></search><sort><creationdate>202012</creationdate><title>Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases</title><author>Stafler, Patrick ; Zaks‐Hoffer, Gal ; Scheuerman, Oded ; Ben‐Zvi, Haim ; Mussaffi, Huda ; Mei‐Zahav, Meir ; Steuer, Guy ; Levine, Hagit ; Bar‐On, Ophir ; Mantin, Hadas ; Prais, Dario ; Blau, Hannah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3573-4c763b043a8aa31ccca97d956f12708d809f0ecae3bac34b6e9e580aa39a65c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>airway infection</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacteria</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>chronic suppurative lung disease</topic><topic>Cystic fibrosis</topic><topic>Cystic Fibrosis - drug therapy</topic><topic>deep suction</topic><topic>Female</topic><topic>Humans</topic><topic>induced sputum</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Lung diseases</topic><topic>Lung Diseases - diagnosis</topic><topic>Lung Diseases - microbiology</topic><topic>Male</topic><topic>Prospective Studies</topic><topic>Pseudomonas aeruginosa</topic><topic>Retrospective Studies</topic><topic>Sputum - microbiology</topic><topic>Suppuration - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stafler, Patrick</creatorcontrib><creatorcontrib>Zaks‐Hoffer, Gal</creatorcontrib><creatorcontrib>Scheuerman, Oded</creatorcontrib><creatorcontrib>Ben‐Zvi, Haim</creatorcontrib><creatorcontrib>Mussaffi, Huda</creatorcontrib><creatorcontrib>Mei‐Zahav, Meir</creatorcontrib><creatorcontrib>Steuer, Guy</creatorcontrib><creatorcontrib>Levine, Hagit</creatorcontrib><creatorcontrib>Bar‐On, Ophir</creatorcontrib><creatorcontrib>Mantin, Hadas</creatorcontrib><creatorcontrib>Prais, Dario</creatorcontrib><creatorcontrib>Blau, Hannah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric pulmonology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stafler, Patrick</au><au>Zaks‐Hoffer, Gal</au><au>Scheuerman, Oded</au><au>Ben‐Zvi, Haim</au><au>Mussaffi, Huda</au><au>Mei‐Zahav, Meir</au><au>Steuer, Guy</au><au>Levine, Hagit</au><au>Bar‐On, Ophir</au><au>Mantin, Hadas</au><au>Prais, Dario</au><au>Blau, Hannah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases</atitle><jtitle>Pediatric pulmonology</jtitle><addtitle>Pediatr Pulmonol</addtitle><date>2020-12</date><risdate>2020</risdate><volume>55</volume><issue>12</issue><spage>3421</spage><epage>3428</epage><pages>3421-3428</pages><issn>8755-6863</issn><eissn>1099-0496</eissn><abstract>Background Acquiring sputum cultures from infants is considered challenging. We describe their yield in infants with cystic fibrosis (CF) and other chronic suppurative lung diseases (CSLDs). Methods Retrospective medical record review over a 4‐year period, for infants aged 0–2 years with ≥2 airway bacterial cultures acquired by deep suction or induced sputum ≥4 weeks apart. Data included demographics, culture results, and clinical status. Results A total of 98 infants (16 CF) were evaluated and 534 sputum cultures acquired, 201 in CF and 333 in CSLD. There were 12 (2–23), median (range) cultures/CF infant, and 3 (2–21)/CSLD infant. Age at first culture was 3.8 (1–19.5) months for CF and 10.4 (0.5–22) months for CSLD; p = .016. In total, 360 cultures (67%) were positive for any bacteria, with 170/234 (73%) positive during exacerbations, compared with 190/300 (63%) during routine visits; p = .05. More infants with CF than CSLD had cultures positive for Staphylococcus aureus (SA; 75% vs. 34%; p = .004) throughout the period. Pseudomonas aeruginosa (PA) was common in both CF and CSLD (56% and 44%, respectively; p = .42) and increased over time for CF but was high throughout for CSLD. The number of hospital days before PA acquisition was 6 (10.2) for CF and 28.8 (38.7) for CSLD (p = .003). No CF but 6/82 (7%) CSLD infants had chronic PA (p = .56). Conclusions Sputum cultures showed that infection, in particular PA, is common in CF and CSLD whereas SA is more common in CF. Prospective studies are warranted to elucidate the role of active surveillance in guiding antibiotic therapy.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33006230</pmid><doi>10.1002/ppul.25103</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-8880-8212</orcidid><orcidid>https://orcid.org/0000-0002-6683-0264</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 8755-6863
ispartof Pediatric pulmonology, 2020-12, Vol.55 (12), p.3421-3428
issn 8755-6863
1099-0496
language eng
recordid cdi_proquest_miscellaneous_2448410680
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects airway infection
Anti-Bacterial Agents - therapeutic use
Bacteria
Child
Child, Preschool
chronic suppurative lung disease
Cystic fibrosis
Cystic Fibrosis - drug therapy
deep suction
Female
Humans
induced sputum
Infant
Infant, Newborn
Lung diseases
Lung Diseases - diagnosis
Lung Diseases - microbiology
Male
Prospective Studies
Pseudomonas aeruginosa
Retrospective Studies
Sputum - microbiology
Suppuration - drug therapy
title Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T17%3A22%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20value%20of%20sputum%20cultures%20in%20children%20under%202%20years%20of%20age%20with%20chronic%20suppurative%20lung%20diseases&rft.jtitle=Pediatric%20pulmonology&rft.au=Stafler,%20Patrick&rft.date=2020-12&rft.volume=55&rft.issue=12&rft.spage=3421&rft.epage=3428&rft.pages=3421-3428&rft.issn=8755-6863&rft.eissn=1099-0496&rft_id=info:doi/10.1002/ppul.25103&rft_dat=%3Cproquest_cross%3E2458504380%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2458504380&rft_id=info:pmid/33006230&rfr_iscdi=true